Back to search
High-risk GD2-Positive Ewing Sarcoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which High-risk GD2-Positive Ewing Sarcoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which High-risk GD2-Positive Ewing Sarcoma trials you may qualify forThe goal of the study is to investigate the feasibility, toxicity, and biological activity of the treatment with dinutuximab beta in combination with standard c…
The purpose of this study is to test the safety and efficacy of GD2-CART01, a CAR T cell treatment targeting GD2 in paediatric or young adult patients with High…